BELOSALIC

Cutaneous solution, 0.5mg/g + 20mg/g
RxActive license

Active substance (INN)

betamethasonesalicylic acid

Pharmaceutical form

Pharmaceutical formCutaneous solution
Strength0.5mg/g + 20mg/g
PackagingUkupno 1 bočica sa kapaljkom sa 50ml rastvora za kožu u kartonskoj kutiji
Manufacturerlijekovi i kozmetika d.d., Croatia
Therapeutic groupDermatologicals (D07BC01)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateDecember 26, 2023

Analogs in Montenegro

8

Other medicines with the same active substance

BELODERMRx
Ointment, 0.5mg/glijekovi i kozmetika d.d.
BELODERMRx
Cream, 0.5mg/glijekovi i kozmetika d.d.
BELOGENTRx
Cream, 0.5mg/g + 1mg/glijekovi i kozmetika d.d.
BELOGENTRx
Ointment, 0.5mg/g + 1mg/glijekovi i kozmetika d.d.
BELOSALICRx
Ointment, 0.5mg/g + 30mg/glijekovi i kozmetika d.d.
DIDERMALRx
Cream, 0.5mg/g + 1mg/gBosnalijek d.d.
DIDERMALRx
Ointment, 0.5mg/g + 1mg/gBosnalijek d.d.
FLOSTERONRx
Suspension for injection, 7mg/mlKrka d.d.
Source: CInMED register